3.90
price up icon0.78%   0.03
after-market Dopo l'orario di chiusura: 3.89 -0.010 -0.26%
loading

Larimar Therapeutics Inc Azioni (LRMR) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
10.89%
27.79
31.19 31.29 18.26 24.60
Operating Income/Loss
10.89%
-27.79
-31.19 -31.29 -18.26 -24.60
Nonoperating Income/Loss
15.57%
1.61
1.907 2.469 2.765 2.972
Income/Loss From Continuing Operations Before Tax
10.58%
-26.18
-29.28 -28.82 -15.50 -21.63
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
10.58%
-26.18
-29.28 -28.82 -15.50 -21.63
Net Income/Loss
10.58%
-26.18
-29.28 -28.82 -15.50 -21.63
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.10%
64.03
63.96 0.8564 63.81 63.80
Diluted Average Shares
0.10%
64.03
63.96 0.8564 63.81 63.80
Basic Earnings Per Share
10.87%
-0.41
-0.46 -0.46 -0.24 -0.34
Diluted Earnings Per Share
10.87%
-0.41
-0.46 -0.46 -0.24 -0.34
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.78
price up icon 0.98%
$84.84
price up icon 1.00%
$24.80
price down icon 8.06%
$103.01
price down icon 1.70%
$134.53
price up icon 1.79%
biotechnology ONC
$300.14
price down icon 2.84%
Capitalizzazione:     |  Volume (24 ore):